Ocular Therapeutix Net Other Investing Changes (Quarterly) Insights

Ocular Therapeutix, Inc. (OCUL)

9.175 -0.32 (-3.42%) USD | NASDAQ | Feb 26, 10:05

View Net Other Investing Changes (Quarterly) for OCUL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Net Other Investing Changes (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Net Other Investing Changes (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Net Other Investing Changes (Quarterly) Benchmarks

Start Trial

Regeneron Pharmaceuticals, Inc.	--
Boston Scientific Corp.	--
Alnylam Pharmaceuticals, Inc.	--
EyePoint Plc	--
Vertex Pharmaceuticals, Inc.	Upgrade